Company Filing History:
1 out of 5 
1 out of 2 Years Active: 2019-2021
Title: Rachael Terry: Innovator in Immune-Modulating Technologies
Introduction
Rachael Terry is an accomplished inventor based in Petersham, Australia, known for her groundbreaking contributions to the field of immunology. With a total of two patents to her name, her work focuses on innovative solutions for mitigating inflammatory immune responses, marking significant advancements in medical treatment options.
Latest Patents
Rachael Terry's latest patents center around modified immune-modulating particles. One of her inventions details methods for reducing the duration or severity of an inflammatory immune response by administering poly (lactic acid) (PLA) particles, poly (glycolic acid) (PGA) particles, and poly (lactic-co-glycolic acid) (PLGA) particles. These particles are uniquely modified to feature one or more carboxyl groups on their surfaces, eschewing the need for therapeutically active ingredients. In another significant finding, Terry’s research into carboxylated particles demonstrates their ability to ameliorate inflammatory immune responses, offering new methods for treating inflammatory diseases.
Career Highlights
Throughout her career, Rachael has made noteworthy contributions to several organizations, including Cour Pharmaceuticals Development Company and Oncour Pharma. Her innovative research and development efforts have positioned her as a leader in her field, exemplifying her commitment to advancing medical science and improving patient outcomes.
Collaborations
Rachael has collaborated with esteemed colleagues, including Daniel R. Getts and Nicholas King. Their collective expertise has fostered significant projects and developments in the arena of immune-modulating therapies. These collaborations showcase the synergy between innovative minds dedicated to pushing the boundaries of scientific research.
Conclusion
Rachael Terry stands as a pioneering inventor in the field of immunology, with her work focusing on innovative approaches to combat inflammation through modified particle technologies. Her contributions have the potential to transform treatment protocols for inflammatory diseases, marking her as a significant figure in medical technology innovation.